India's Gufic Biosciences rises on patent grant

Gufic Biosciences

15/09/2023 06:20

** Shares of Gufic Biosciences  GUFI.NS  up as much as 4.57%
to 310 rupees
    ** Stock on track for third consecutive session of gains 
    ** Active pharmaceutical ingredients maker said it has been
granted 20-year patent for Omadacycline Tosylate, a component
used in drugs
    ** About 201,355 shares change hands as of 10:42 a.m. IST,
0.5x 30-day average 
    ** Stock up ~31% so far this year, as of last close

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))